(Q40613241)

English

Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells.

scientific article published on November 2003

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

title

Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

1 reference

Karin M Kirschner

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Kurt Baltensperger

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

publication date

1 November 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

published in

Molecular Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

issue

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

page(s)

970-980

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Identifiers

PubMed publication ID

14638869

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14638869

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14638869%20AND%20SRC:MED&resulttype=core&format=json

(Q40613241)

Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)